Related Experiment Videos
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease
Insights
Decreased high-density-lipoprotein (HDL) cholesterol levels correlate with an increased body cholesterol pool. This suggests HDL plays a crucial role in cholesterol transport and may impact ischemic heart disease risk.
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
Background:
- High-density-lipoprotein (HDL) cholesterol is inversely related to the body's cholesterol pool.
- Reduced HDL levels are observed in conditions linked to increased ischemic heart disease (IHD) risk.
Purpose of the Study:
- To investigate the relationship between HDL cholesterol and the body's cholesterol pool.
- To explore the role of HDL in cholesterol transport and its implications for atherosclerosis and IHD.
Main Methods:
- Analysis of body cholesterol pool in relation to plasma HDL concentrations.
- Comparison of HDL levels in subjects with and without existing IHD.
Main Results:
- Body cholesterol pool size increases as plasma HDL concentration decreases.
- Plasma HDL levels are not correlated with total cholesterol or other lipoproteins.
- Subjects with existing IHD exhibit lower HDL levels compared to healthy individuals.
Conclusions:
- HDL facilitates cholesterol uptake from peripheral tissues and transport to the liver for excretion.
- Reduced HDL may accelerate atherosclerosis and IHD development by impairing arterial cholesterol clearance.
Abstract:
The body cholesterol pool increases with decreasing plasma-high-density-lipoprotein (H.D.L.) but is unrelated to the plasma concentrations of total cholesterol and other lipoproteins. This finding supports existing evidence that H.D.L. facilitates the uptake of cholesterol from peripheral tissues and its transport to the liver for catabolism and excretion. Plasma-H.D.L., is reduced in several conditions associated with an increased risk of future ischaemic heart-disease (I.H.D.), namely hypercholesterolaemia, hypertriglyceridaimia, male sex, obesity, and diabetes mellitus, while subjects with existing clinical I.H.D. have lower levels of H.D.L. than healthy subjects within the same community. It is proposed that a reduction of plasma-H.D.L. concentration may accelerate the development of atherosclerosis, and hence I.H.D., by impairing the clearance of cholesterol from the arterial wall.